Clinical Perspectives

Comparing TILs, CAR-T, and BiTEs: Advances in Immunotherapy for Targeted Cancer Treatment

Consider Moffitt Cancer Center’s leadership in immunotherapy treatment when you need cutting-edge care for your patients.

Key Differences Between Colon Cancer and Rectal Cancer Surgical Care

Key Differences Between Colon Cancer and Rectal Cancer Surgical Care in the Gastrointestinal Oncology Program at Moffitt Cancer Center

Navigating New Frontiers: Far Medial Technique in Minimally Invasive Brain Tumor Surgery

For lesions requiring surgery in the clivus region, navigating these intricate structures near the base of the brain requires high precision.

Precision Surgery and Its Role in Genitourinary Cancer Therapy

At Moffitt, we specialize in advanced surgical procedures such as MIS to complex reconstructive surgeries.

Moffitt Physicians Honored at ASTRO 2024

Drs. Anupam Rishi and Michael Yu were recognized at the 2024 Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Breakthrough Treatment for Small Cell Lung Cancer: New Therapy Offers Hope for Advanced-Stage Patients

Moffitt is proud to be the first institution in the United States to offer tarlatamab as a standard treatment for patients with extensive-stage SCLC.

Targeted Triumph: Precision Surgery for Breast Cancer

The SmartClip® technology for breast cancer surgery represents a significant advancement in our surgeons' ability to precisely localize and remove...

Revolutionizing Treatment for Node-Positive Melanoma: Neoadjuvant Therapy

Neoadjuvant therapy is advancing the fight against this aggressive form of skin cancer, creating a new standard of care. 

SCOUTMD® Radar Localization and Breast Cancer Surgery

The Breast Oncology Program at Moffitt Cancer Center is proud to be the first cancer center in the U.S. to offer SCOUTMD® Radar Localization.

Comprehensive Care for Endocrine Tumors at Moffitt

The Endocrine Oncology Program offers specialized care for both malignant and benign endocrine tumors using advanced techniques for complex cases.

Advancing Endometrial Cancer Treatment with Targeted Therapies

In June, the FDA approved the use of Durvalumab with carboplatin plus paclitaxel followed by single-agent durvalumab for patients with primary...

FDA Approval of Percutaneous Hepatic Perfusion Offers Patients New Hope

The FDA recently approved Percutaneous Hepatic Perfusion (PHP) with the HEPZATO KIT to treat metastatic uveal melanoma.

FDA Approves New Gene Therapy for Synovial Sarcoma

The FDA granted accelerated approval for Tecelra (afamitresgene autoleucel), a groundbreaking gene therapy for metastatic synovial sarcoma.

Q&A: Insights on Oral Cavity Cancer Treatment

Due to their aggressive nature, it's crucial to have treatment by an experienced surgeon and a multidisciplinary team from the first diagnosis of...

Minimally Invasive Surgery Advancements for Spinal Tumor Surgery

The Minimally Invasive Spine Oncology (MISO) program is patient-centered with a focus on the use of minimal access techniques for the treatment of...